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Introduction
Adipose-derived stem cells (ASCs)
• popular candidates for cell-based therapies
• easily harvested
• cultured from liposuction fat
• in an outpatient setting with minimal risk of Complications
• large quantities harvested from a small amount of fat.
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Introduction
Adipose-derived stem cells (ASCs)
• four or more passages without altering growth or differentiation 
• can be expanded 3000-fold or more a few weeks
• 10 mL of fat to be expanded to 3 billion or more ASCs
• capable of replacing a number of tissues
including bone, cartilage, muscle, and fat.
•
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Introduction
Adipose-derived stem cells (ASCs)
• complex paracrine mediators of tissue repair and regeneration
• attract host regenerative cells to the site of injury.
• augmenting wound healing, particularly in difficult
injuries such as non healing wounds or burn wounds.
• uniform standards for dose and delivery are not yet established
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Introduction
Rodent model
• differs from human skin both structurally and functionally
porcine model
• structurally similar to human skin
• employs similar repair mechanisms following injury.
• widely used in wound healing studies for more than 30 y.
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Introduction
previous studies
Hadad et al
• improved wound vascularization and closure
• combination of ASCs and platelet-rich plasma
study aims
• Standardized model of cell dose and delivery
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Materials and methods
1. Isolating and preparing ASCs
2. Tracking ASCs
3. Animals
4. Wounding and treatment
5. Dressing changes
6. Wound harvest and assessment
7. Real-time quantitative reverse transcriptase polymerase
chain reaction
8. Western blots
9. Statistics
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Materials and methods
Isolating and preparing ASCs
• porcine inguinal adipose Allogeneic adipose stem cells
1. manually chopped
2. digested in double strength collagenase solution
3. shaking in a 37˚C water bath for 45-60 min
4. centrifuged for 10 min at 180 g 
5. filtered using 2-ply gauze to remove large debris
6. cellular pellet was resuspended in erythrocyte lysis buffer
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Materials and methods
Isolating and preparing ASCs
7.centrifuged at 180 g for 10 min stromal vascular fraction
8. Falcon 175𝑐𝑚2 tissue culture-treated flasks in general ASC culture 
medium
Dulbecco’s Modified Eagle medium/Nutrient: F12
10% fetal bovine serum
1%penicillin/streptomycin
1% Fungizone 
9. overnight incubation                                                                  
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Materials and methods
Isolating and preparing ASCs
10.Non adherent cells were removed
10. the cell medium was replaced with fresh plating medium
11. ASCs were then expanded in culture and passaged
12. 70%-80% confluency lifted using trypsin
13. -80˚C in freezing medium:  10% fetal bovine serum
40% Dulbecco’s Modified Eagle medium
10 % dimethyl sulfoxide
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Materials and methods
Isolating and preparing ASCs
week of surgery
15.culture for 3 d to allow recovery
16. ASCs were lifted, counted, and assessed for viability
Tracking ASCs
1.ASCs were lifted and stained with PKH26
(a nontoxic fluorescent marker of cell membranes)
2. washing
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Materials and methods
Tracking ASCs
3. sterile phosphate-buffered saline (1.3, 4.2, or 12.6 million cells/mL)
4. Aliquote into sterile 3 mL syringes 
Animals
• Six-month-old (w70 kg) female Yorkshire pigs
• approval by the Institutional Animal Care.
• Committee of the University of Pittsburgh
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Materials and methods
Animals
• housed in individual cages after wounding
• maintained under a 12-h light/dark cycle
• temperature in accordance with guidelines approved by the 
Institutional Animal Care and Use Committee.
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Materials and methods
Wounding and treatment
• Two authors 
• groups evenly distributed between them
• Forty (n = 8 per group) full-thickness circular wounds,
• 4 cm in diameter were created on the animals’ dorsum using sharp 
excision
• A template was employed to standardize wound dimensions.
• Cells were injected at low, medium, and high doses 
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Materials and methods
Wounding and treatment
The low dose: 0.3 × 106ASCs/𝑐𝑚2(3.8×106cells/wound)
the medium dose: 1.0×106ASCs/𝑐𝑚2 (12.6×106cells/wound)
the high dose: 3.0 × 106ASCs/cm2 (3.8  ×107cells/wound)
• Controls: sham injections of saline 
standard wound care without injection. 
• Treatment locations were randomized 
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Materials and methods
Wounding and treatment
• Cell injections were distributed 
evenly around the wound
• 1 mL        superficial wound bed
• 2 mL Intradermally
• Tegaderm dressings and OpSite
• A cotton pad and pig jacket 
to further protect
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Materials and methods
Dressing changes
• twice weekly 
• gentle debridement of fibrinous exudate 
• saline rinsing as appropriate
• Photographed
• traced onto clear plastic to track contraction and epithelialization.
• Dressings were reapplied
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Materials and methods
Dressing changes
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Materials and methods
Wound harvest and assessment
• Animals were sacrificed
at 1 and 2 wk time points 
• Wounds were excised to fascia
• Central wound were taken for histology
• Samples fixed: 
Bouin’s solution
or
frozen in Tissue-Tek O.C.T
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Materials and methods
Wound harvest and assessment
• Masson’s trichrome stain
 Basic tissue architecture 
Neodermal thickness
• Fluorescent microscope :PKH-labeled exogenous ASCs.
• horseradish peroxidase :CD31 was assessed 
• Metamorph image analysis software:  
contraction and epithelialization were assessed
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Materials and methods
Real-time quantitative reverse transcriptase PCR
• α-SMA(α-smooth muscle actin)
• Col1a1:Col3a1 ratio
• Samples were preserved in 900 μL of RNALater
• Stored at -20˚C
• homogenized and digested with 20 mg/mL Proteinase K
• RNA was eluted in RNase-free water
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Materials and methods
Real-time quantitative reverse transcriptase PCR
• 500 ng of RNA was used as the template for cDNA
• final cDNA reaction was diluted 10x.
• 2µL was mixed with 5µL fast SYBR-green master mix.
• 3µL of primers mix specific to the target gene.
• The 2−ΔΔ𝑐𝑡 method
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Materials and methods
Western blots
• CD31 and α-SMA.
• liquid nitrogen.
• lysis buffer on ice for 10 min.
• centrifugation at 12,000 g for 30 min.
• The supernatants were collected as whole cell extracts.
• lysates were concentrated by adding less lysis buffer
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Materials and methods
Western blots
• protein concentrations. (bicinchoninic acid protein assay kit)
• polyacrylamide gel electrophoresis
• transferred onto nitrocellulose membranes,
• incubation with primary antibodies at 4˚C overnight
• washing
• HRP-conjugated  secondary  anti-bodies at room temperature for 1 h
• Proteins were detected with an enhanced chemiluminescence kit 
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Materials and methods
Western blots
• Loading control
 Glyceraldehyde 3-phosphate dehydrogenase
Or
Β-tubulin
• Epson Perfection V600 photo scanner
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Materials and methods
Statistics
• Mean ± standard error of the mean
• P <0.05
• SPSS statistical software
30
Results
Wound contraction and dermal thickness
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Results
Wound contraction and dermal thickness
• %wound contraction:
original wound area -current wound area/original wound area
• High dose ASCs compared to saline injected  controls:
greater wound contraction at day 10 (p =0.12)
reached significance at day 14 (p = 0.04)
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Results
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Results
Wound contraction and dermal thickness
• Masson’s trichrome at 1 wk
postoperative
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Results
Wound contraction and dermal thickness
• blinded observer
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Results
Cell tracking
• PKH26-labeled ASC in deep neodermis
• 1 and 2 wk postoperative
• Magnification of 20×
• red (PKH 26) 
• Blue (4’,6-diamidino-2-phenylindole) 
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Results
Cell tracking
1 wk postoperative                        at 2 wk
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Results
Quantitative RT-PCR
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Results
Quantitative RT-PCR and western blot
39
Results
Western Blot
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Results
Immunohistochemistry
• Meta morph software
• Per-pixel quantification
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Discussion
ASC
• Well tolerated (if cultured)
• persist in the wound for at least 2 wk.
• the transient paracrine mediators do not survive long term
• reduce histocompatibility antigen presentation.
• ability to use in large animals:
the establishment of standardized cell banks
The flexibility of adipose stem cell-based treatments
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Discussion
• did not significantly reduce time to epithelial coverage, 
• high dose ASC enhance the rate of wound contraction
• enhanced neodermal thickness at 7 d.(reduce infection risk)
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Discussion
ASC Dose dependent improvements
• CD31
• Col1:Col3 ratio
• α-SMA
• average vessel size
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Discussion
hypoxia or injury 
ASC                     VEGF                  matrix metalloproteinases
collagen  remodeling   
reduced Col1:Col3 ratio in the medium dose group at day 14
reduced scar         
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Discussion
α- SMA
• high dose group at 2 wk α- SMA
consistent with:
the enhanced wound contraction between day 10 and 14
• a reliable marker for myoepithelial cells’ contractile activity.
• ASC            TGF-β α- SMA
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Discussion
Limitations
• only acute phase of wound healing
• did not follow animals beyond 2 wk
• 4cm wounds are not a critical size defect
• Many of the effects only occurred at doses of 3 million cells/cm2
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